Literature DB >> 28347435

Expanding engagement with the ethical implications of changing definitions of Alzheimer's disease.

Richard Milne1, Jason Karlawish2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28347435      PMCID： PMC5898807          DOI： 10.1016/S2215-0366(17)30089-5

Source DB:  PubMed          Journal:  Lancet Psychiatry        ISSN： 2215-0366            Impact factor:   27.083


× No keyword cloud information.
  5 in total

1.  The 'D' word: Reflections on the relationship between stigma, discrimination and dementia.

Authors:  Alison Milne
Journal:  J Ment Health       Date:  2010-06

2.  The relative contributions of disease label and disease prognosis to Alzheimer's stigma: A vignette-based experiment.

Authors:  Rebecca Johnson; Kristin Harkins; Mark Cary; Pamela Sankar; Jason Karlawish
Journal:  Soc Sci Med       Date:  2015-08-18       Impact factor: 4.634

3.  Addressing the ethical, policy, and social challenges of preclinical Alzheimer disease.

Authors:  Jason Karlawish
Journal:  Neurology       Date:  2011-09-14       Impact factor: 9.910

Review 4.  Can we prevent Alzheimer's disease? Secondary "prevention" trials in Alzheimer's disease.

Authors:  Maria C Carrillo; H Robert Brashear; Veronika Logovinsky; J Michael Ryan; Howard H Feldman; Eric R Siemers; Susan Abushakra; Dean M Hartley; Ronald C Petersen; Ara S Khachaturian; Reisa A Sperling
Journal:  Alzheimers Dement       Date:  2013-02-12       Impact factor: 21.566

Review 5.  Psychological, behavioral and social effects of disclosing Alzheimer's disease biomarkers to research participants: a systematic review.

Authors:  S A S A Bemelmans; K Tromp; E M Bunnik; R J Milne; S Badger; C Brayne; M H Schermer; E Richard
Journal:  Alzheimers Res Ther       Date:  2016-11-10       Impact factor: 6.982
  5 in total
  3 in total

1.  Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults.

Authors:  Jessica Mozersky; Pamela Sankar; Kristin Harkins; Sara Hachey; Jason Karlawish
Journal:  JAMA Neurol       Date:  2018-01-01       Impact factor: 18.302

2.  The Institute on Methods and Protocols for Advancement of Clinical Trials in ADRD (IMPACT-AD): A Novel Clinical Trials Training Program.

Authors:  T Berkness; M C Carrillo; R Sperling; R Petersen; P Aisen; C Flournoy; H Snyder; R Raman; J D Grill
Journal:  J Prev Alzheimers Dis       Date:  2021

3.  Ethical Implications of Alzheimer's Disease Prediction in Asymptomatic Individuals through Artificial Intelligence.

Authors:  Frank Ursin; Cristian Timmermann; Florian Steger
Journal:  Diagnostics (Basel)       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.